for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca drug Tagrisso gets EU nod for early lung cancer treatment

May 28 (Reuters) - AstraZeneca Plc said on Friday the European Commission has approved its Tagrisso drug to treat patients with a type of early-stage lung cancer.

The approval was based on positive results from a late-stage trial called ADAURA, where Tagrisso cut by 80% the risk of the tumour growing back in patients, or risk of death due to the disease.

The lung cancer drug was approved in the United States for a similar indication in December 2020 based on the same trial. (Reporting by Vishwadha Chander in Bengaluru; Editing by Devika Syamnath)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up